Brown’s Martin Keller, Glaxo & Paxil Study 329
3 CommentsBy Ed Silverman // September 23rd, 2008 // 10:35 am
How’s this for school spirit? A pair of Brown University students have worked up a nicely done look back at the infamous professor. Keller, you may recall, is among the 30 or so physicians at two dozen universities the Senate Finance Committee is probing concerning disclosure of grants from drugmakers. The Brown psychiatrist is a controversial figure for his role in studying Glaxo’s Paxil antidepressant.
Why? He was the lead author of an infamous study published in 2001 in the Journal of the American Academy of Child and Adolescent Psychiatry that Paxil was “generally well tolerated and effective for major depression in adolescents.” Study 329 was used to widely promote the pill, which became a huge seller, but was plagued by ghostwriting charges, and results were worse than imagined.
Those crazy college kids - we call them Chaz & Chaz - sum up the controversy here and here. Showing disdain for their own college newspaper, Brown officials continue to stonewall questioners, as they did when we broke the story in July.
dtyikcyvlbk
Keller’s got brown stuff all over his face.
Erik
Why would he not want Brown all over his face? They are certainly all over the cover up.
Thom
Keller, what a tool. Even college journalists pick him apart.